David Shaw’s CareDx CDNA Stock Holding History

David Shaw’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,900	Closed	-$324K	–	3617
2018 Q4	$324K	Buy	+12,900	New	+$331K	﹤0.01%	3305

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's CDNA Position: Q2 2026 in Review

David Shaw increased its CareDx (CDNA) stake by 30% in Q2 2026, buying an estimated $5.72M and bringing the position to 1,137,660 shares worth $32.4M. The position accounts for 0.02% of the portfolio, ranked #1003.

David Shaw first reported a position in CDNA in Q2 2018 and has held it in 33 quarters since. The position peaked at $89M in Q4 2020. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

David Shaw held 1,137,660 shares of CareDx worth $32.4M as of Q2 2026.
David Shaw bought 262,752 CareDx shares in Q2 2026, an estimated $5.72M.
CareDx made up 0.02% of David Shaw's portfolio in Q2 2026, its #1003 holding.
David Shaw first reported a position in CareDx in Q2 2018 and has held it in 33 quarters since.
David Shaw's CareDx position peaked at $89M in Q4 2020.
225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.